NEW YORK (GenomeWeb) – Namocell, a developer of microfluidic-based single-cell sorting and capturing platforms, has announced a collaboration with researchers at Massachusetts General Hospital to research circulating tumor cells.
Registering provides access to this and other free content.
Already have an account?Login Now.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.
Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.
In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.
This webinar will provide an overview of how liquid biopsies can be integrated into lung cancer care.
This webinar describes the characterization of gene fusions across distinct subtypes of melanoma.